Sarah Duellman

987 total citations · 1 hit paper
19 papers, 745 citations indexed

About

Sarah Duellman is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Sarah Duellman has authored 19 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Sarah Duellman's work include bioluminescence and chemiluminescence research (5 papers), Viral-associated cancers and disorders (4 papers) and 3D Printing in Biomedical Research (3 papers). Sarah Duellman is often cited by papers focused on bioluminescence and chemiluminescence research (5 papers), Viral-associated cancers and disorders (4 papers) and 3D Printing in Biomedical Research (3 papers). Sarah Duellman collaborates with scholars based in United States, Finland and Australia. Sarah Duellman's co-authors include Terry Riss, Richard A Moravec, Andrew L. Niles, Lisa Minor, Hélène A Benink, Tracy J Worzella, Richard R. Burgess, James J. Cali, Wenhui Zhou and John Shultz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Sarah Duellman

18 papers receiving 738 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell Viability Assays

2016 349 citations Terry Riss, Richard A Moravec et al. Europe PMC (PubMed Central) profile →

Peers

Sarah Duellman

ONCOL

EPIDE

Huixia Zhang China

V. V. Dmitrenko Ukraine

Qun Chen China

Ramya Krishna Vadlapatla United States

Aeri Kim South Korea

María Victoria Aguirre Argentina

Li Du China

Xinglu Zhou China

Erica Miraglia Italy

Huixia Zhang China

Sarah Duellman

334 ×0.9

110 ×0.9

ONCOL

100 ×1.1

97 ×1.3

76 ×1.2

EPIDE

Citations per year, relative to Sarah Duellman Sarah Duellman (= 1×) peers Huixia Zhang

Countries citing papers authored by Sarah Duellman

Since Specialization

Citations

This map shows the geographic impact of Sarah Duellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Duellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Duellman more than expected).

Fields of papers citing papers by Sarah Duellman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Duellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Duellman. The network helps show where Sarah Duellman may publish in the future.

Co-authorship network of co-authors of Sarah Duellman

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Duellman. A scholar is included among the top collaborators of Sarah Duellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Duellman. Sarah Duellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Riss, Terry, Richard A Moravec, Sarah Duellman, & Andrew L. Niles. (2021). Treating Cells as Reagents to Design Reproducible Assays. SLAS DISCOVERY. 26(10). 1256–1267. 8 indexed citations

Duellman, Sarah, Thomas Machleidt, James J. Cali, & Jolanta Vidugirienė. (2017). Cell-based, bioluminescent assay for monitoring the interaction between PCSK9 and the LDL receptor. Journal of Lipid Research. 58(8). 1722–1729. 7 indexed citations

Walker, Joel R., Mary P. Hall, Chad Zimprich, et al.. (2017). Highly Potent Cell-Permeable and Impermeable NanoLuc Luciferase Inhibitors. ACS Chemical Biology. 12(4). 1028–1037. 30 indexed citations

Riss, Terry, Richard A Moravec, Andrew L. Niles, et al.. (2016). Cell Viability Assays. Europe PMC (PubMed Central). 349 indexed citations breakdown →

Duellman, Sarah, Wenhui Zhou, Poncho Meisenheimer, et al.. (2015). Bioluminescent, Nonlytic, Real-Time Cell Viability Assay and Use in Inhibitor Screening. Assay and Drug Development Technologies. 13(8). 456–465. 52 indexed citations

Cali, James J., et al.. (2015). Altered cytotoxicity of ROS-inducing compounds by sodium pyruvate in cell culture medium depends on the location of ROS generation. SpringerPlus. 4(1). 269–269. 42 indexed citations

Riss, Terry, Brad Hook, & Sarah Duellman. (2015). Evaluation of real time cell viability assays multiplexed with other methods. Toxicology Letters. 238(2). S179–S180. 5 indexed citations

Laderoute, Keith R., Joy M. Calaoagan, Wan‐Ru Chao, et al.. (2014). 5′-AMP-activated Protein Kinase (AMPK) Supports the Growth of Aggressive Experimental Human Breast Cancer Tumors. Journal of Biological Chemistry. 289(33). 22850–22864. 57 indexed citations

Zhou, Wenhui, Donna Leippe, Sarah Duellman, et al.. (2014). Self‐Immolative Bioluminogenic Quinone Luciferins for NAD(P)H Assays and Reducing Capacity‐Based Cell Viability Assays. ChemBioChem. 15(5). 670–675. 25 indexed citations

10.

Duellman, Sarah, Jolanta Vidugirienė, Wenhui Zhou, et al.. (2014). Abstract 3743: Bioluminescent, non-lytic, real-time cell viability assay. Cancer Research. 74(19_Supplement). 3743–3743.

11.

Duellman, Sarah, Michael P. Valley, Vinayaka Kotraiah, et al.. (2012). A bioluminescence assay for aldehyde dehydrogenase activity. Analytical Biochemistry. 434(2). 226–232. 13 indexed citations

12.

Malerich, Jeremiah P., et al.. (2011). A High-Throughput Fluorescence Polarization Assay for Inhibitors of Gyrase B. SLAS DISCOVERY. 16(2). 230–238. 10 indexed citations

13.

Duellman, Sarah, Joy M. Calaoagan, Barbara Sato, et al.. (2010). A novel steroidal inhibitor of estrogen-related receptor α (ERRα). Biochemical Pharmacology. 80(6). 819–826. 25 indexed citations

14.

Sun, Xiaoping, Elizabeth A. Barlow, Shidong Ma, et al.. (2010). Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism. Proceedings of the National Academy of Sciences. 107(7). 3146–3151. 63 indexed citations

15.

Duellman, Sarah, et al.. (2009). Phosphorylation sites of Epstein-Barr virus EBNA1 regulate its function. Journal of General Virology. 90(9). 2251–2259. 25 indexed citations

16.

Duellman, Sarah & Richard R. Burgess. (2009). Antigen-Binding Properties of Monoclonal Antibodies Reactive with EBNA1 and Use in Immunoaffinity Chromatography. PLoS ONE. 4(2). e4614–e4614. 5 indexed citations

17.

Duellman, Sarah & Richard R. Burgess. (2008). Large-scale Epstein–Barr virus EBNA1 protein purification. Protein Expression and Purification. 63(2). 128–133. 4 indexed citations

18.

Duellman, Sarah & Richard R. Burgess. (2005). Overproduction in Escherichia coli and purification of Epstein–Barr virus EBNA-1. Protein Expression and Purification. 47(2). 434–440. 9 indexed citations

19.

Duellman, Sarah, Nancy E. Thompson, & Richard R. Burgess. (2004). An epitope tag derived from human transcription factor IIB that reacts with a polyol-responsive monoclonal antibody. Protein Expression and Purification. 35(1). 147–155. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact